Molecular Weight:   | 338.15 |
Volume:   | 366.092 |
LogP:   | 4.205 |
LogD:   | 3.726 |
LogS:   | -4.19 |
# Rotatable Bonds:   | 6 |
TPSA:   | 66.76 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 4 |
QED Drug-Likeness Score:   | 0.463 |
Synthetic Accessibility Score:   | 2.596 |
Fsp3:   | 0.19 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Rejected |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.862 |
MDCK Permeability:   | 1.8569664462120272e-05 |
Pgp-inhibitor:   | 0.954 |
Pgp-substrate:   | 0.002 |
Human Intestinal Absorption (HIA):   | 0.004 |
20% Bioavailability (F20%):   | 0.006 |
30% Bioavailability (F30%):   | 0.002 |
Blood-Brain-Barrier Penetration (BBB):   | 0.083 |
Plasma Protein Binding (PPB):   | 100.33226013183594% |
Volume Distribution (VD):   | 0.488 |
Pgp-substrate:   | 0.6346591114997864% |
CYP1A2-inhibitor:   | 0.933 |
CYP1A2-substrate:   | 0.866 |
CYP2C19-inhibitor:   | 0.91 |
CYP2C19-substrate:   | 0.112 |
CYP2C9-inhibitor:   | 0.864 |
CYP2C9-substrate:   | 0.95 |
CYP2D6-inhibitor:   | 0.919 |
CYP2D6-substrate:   | 0.906 |
CYP3A4-inhibitor:   | 0.826 |
CYP3A4-substrate:   | 0.38 |
Clearance (CL):   | 2.94 |
Half-life (T1/2):   | 0.741 |
hERG Blockers:   | 0.04 |
Human Hepatotoxicity (H-HT):   | 0.109 |
Drug-inuced Liver Injury (DILI):   | 0.28 |
AMES Toxicity:   | 0.13 |
Rat Oral Acute Toxicity:   | 0.365 |
Maximum Recommended Daily Dose:   | 0.812 |
Skin Sensitization:   | 0.931 |
Carcinogencity:   | 0.604 |
Eye Corrosion:   | 0.019 |
Eye Irritation:   | 0.947 |
Respiratory Toxicity:   | 0.762 |
Natural Product ID:   | NPC23870 |
Common Name*:   | Licoagrochacone A |
IUPAC Name:   | (E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one |
Synonyms:   | |
Standard InCHIKey:   | KAZSKMJFUPEHHW-DHZHZOJOSA-N |
Standard InCHI:   | InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+ |
SMILES:   | C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(cc2)O)c(cc1O)OC |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL139702 |
PubChem CID:   |
5318998 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | stem | n.a. |
PMID[12575075] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[12575075] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | Leaves | n.a. | n.a. |
PMID[12713396] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | whole plant | n.a. |
PMID[15577255] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[16441081] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[16675659] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | roots | n.a. | n.a. |
PMID[20022509] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21123068] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21866899] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[22074222] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22074222] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23325115] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[23541646] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | rhizome | n.a. |
PMID[23867078] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[23867078] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24479468] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | roots | n.a. | n.a. |
PMID[24957203] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[25445757] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[25744461] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26841168] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[28140583] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[28522265] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[29641206] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[30188125] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[32196343] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[7381508] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO2340 | Caulis spatholobi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO23019 | Glycyrrhiza kansuensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO2340 | Caulis spatholobi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO277 | Caulis millettiae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23019 | Glycyrrhiza kansuensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23019 | Glycyrrhiza kansuensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7154 | Glycyrrhiza uralensis | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10026 | Mitracarpus scaber | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO29384 | Glycyrrhiza glabra | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1698 | Glycyrrhiza inflata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO29463 | Pogostemon cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7786 | Lentinus tigrinus | Species | Lentinaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | IC50 | = | 19100.0 | nM | PMID[515154] |
NPT984 | Cell Line | Hepatocyte | TC50 | = | 6.34 | 10'4nM | PMID[515156] | |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 4.2 | ug.mL-1 | PMID[515158] |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 5.42 | ug.mL-1 | PMID[515158] |
NPT344 | Individual Protein | Sialidase | Clostridium perfringens | IC50 | = | 6.9 | ug.mL-1 | PMID[515158] |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 17.98 | ug.mL-1 | PMID[515158] |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 18.23 | ug.mL-1 | PMID[515158] |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 19.09 | ug.mL-1 | PMID[515158] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | IC50 | = | 19100.0 | nM | PMID[515159] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI | = | 10.0 | % | PMID[515168] |
NPT660 | Cell Line | SW480 | Homo sapiens | GI | = | 7.0 | % | PMID[515168] |
NPT65 | Cell Line | HepG2 | Homo sapiens | GI | = | 14.0 | % | PMID[515168] |
NPT2615 | Cell Line | HEK-293T | Homo sapiens | GI | = | 4.0 | % | PMID[515168] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 39.0 | % | PMID[515168] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | Inhibition | = | 18.0 | % | PMID[515168] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | FC | = | 4.07 | n.a. | PMID[515169] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Activity | > | 60.0 | % | PMID[515169] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | Inhibition | = | 14.5 | % | PMID[515170] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | FC | = | 4.1 | n.a. | PMID[515170] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 14.2 | % | PMID[515170] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 57.9 | % | PMID[515170] |
NPT81 | Cell Line | A549 | Homo sapiens | Inhibition | = | 17.8 | % | PMID[515170] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Inhibition | = | 55.9 | % | PMID[515170] |
NPT660 | Cell Line | SW480 | Homo sapiens | Inhibition | = | 13.6 | % | PMID[515170] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | FC | = | 0.8 | n.a. | PMID[515170] |
NPT1166 | Individual Protein | Angiotensin-converting enzyme | Homo sapiens | Inhibition | = | 110.83 | % | PMID[515171] |
NPT2451 | Cell Line | NCI-H28 | Homo sapiens | IC50 | = | 30000.0 | nM | PMID[515176] |
NPT2138 | Cell Line | MSTO-211H | Homo sapiens | IC50 | = | 26000.0 | nM | PMID[515176] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 22000.0 | nM | PMID[515176] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 22000.0 | nM | PMID[515176] |
NPT1374 | Cell Line | WI-38 | Homo sapiens | IC50 | = | 90200.0 | nM | PMID[515176] |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 48500.0 | nM | PMID[515176] |
NPT2245 | Cell Line | SiHa | Homo sapiens | IC50 | = | 42200.0 | nM | PMID[515176] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | IC50 | = | 19100.0 | nM | PMID[515178] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | IC50 | = | 10750.0 | nM | PMID[515179] |
NPT1535 | Cell Line | U-87 MG | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 35.93 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 43.13 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 20.94 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 21.99 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 45.83 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 24.18 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 24.76 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 41.29 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 33.95 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 80.5 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 1.26 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 15.2 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 3.13 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 64.1 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 4.97 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 26.6 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 4.4 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 42.0 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 0.82 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 54.4 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Activity | = | 2.79 | % | PMID[515179] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | Inhibition | > | 50.0 | % | PMID[515179] |
NPT1385 | Individual Protein | Histone-lysine N-methyltransferase SETD7 | Homo sapiens | Inhibition | = | 39.0 | % | PMID[515181] |
NPT1385 | Individual Protein | Histone-lysine N-methyltransferase SETD7 | Homo sapiens | Inhibition | = | 28.0 | % | PMID[515181] |
NPT1385 | Individual Protein | Histone-lysine N-methyltransferase SETD7 | Homo sapiens | Inhibition | = | 17.0 | % | PMID[515181] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 8.67 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 7.99 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 8.9 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 9.03 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 1.0 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 1.1 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 0.9 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 0.31 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 0.3 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 0.28 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 0.7 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 0.8 | n.a. | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | IC50 | = | 53570.0 | nM | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | IC50 | = | 49260.0 | nM | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | IC50 | = | 66650.0 | nM | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | IC50 | = | 56470.0 | nM | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | FC | = | 1.2 | n.a. | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | FC | = | 1.3 | n.a. | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | FC | = | 1.0 | n.a. | PMID[515182] |
NPT1594 | Individual Protein | Multidrug resistance-associated protein 1 | Homo sapiens | FC | = | 1.1 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 5.11 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 4.6 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 4.74 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 4.78 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 18.75 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 7.09 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 7.83 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 6.22 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 26.83 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 24.72 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 25.89 | nM | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 25.55 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 90.05 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 51.47 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 44.11 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 42.41 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 2.2 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 3.9 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 4.6 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 4.7 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 39470.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 6800.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 2630.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 1530.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 1.9 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 10.8 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 28.0 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 48.1 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 1030.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 610.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 410.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 310.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 9.8 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 16.6 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 24.7 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 32.7 | n.a. | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 25.91 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 19.84 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 20.1 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 20.34 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | FC | = | 0.8 | n.a. | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | FC | = | 1.1 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 441.96 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 86.46 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 74.77 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 69.86 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 2.6 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 13.4 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 15.5 | n.a. | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 25.54 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 22.41 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 21.69 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 22.52 | nM | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | FC | = | 1.5 | n.a. | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | FC | = | 1.7 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 366.91 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 143.89 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 147.56 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 130.38 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 3.6 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 9.2 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 8.9 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 10.1 | n.a. | PMID[515182] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 10000.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | EC50 | = | 14000.0 | nM | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | Activity | = | 150.0 | % | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 2.7 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 7.1 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 6.5 | n.a. | PMID[515182] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | FC | = | 8.1 | n.a. | PMID[515182] |
NPT71 | Cell Line | HEK293 | Homo sapiens | IC50 | = | 10000.0 | nM | PMID[515182] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 13000.0 | nM | PMID[515145] |
NPT27 | Others | Unspecified | IC50 | = | 48000.0 | nM | PMID[515145] | |
NPT841 | Organism | Leishmania major | Leishmania major | Inhibition | = | 96.0 | % | PMID[515146] |
NPT841 | Organism | Leishmania major | Leishmania major | Inhibition | = | 91.9 | % | PMID[515146] |
NPT841 | Organism | Leishmania major | Leishmania major | Inhibition | = | 63.9 | % | PMID[515146] |
NPT841 | Organism | Leishmania major | Leishmania major | Inhibition | = | 3.6 | % | PMID[515146] |
NPT27 | Others | Unspecified | Inhibition | = | 65.3 | % | PMID[515146] | |
NPT27 | Others | Unspecified | Inhibition | = | 39.7 | % | PMID[515146] | |
NPT27 | Others | Unspecified | Inhibition | = | 20.8 | % | PMID[515146] | |
NPT27 | Others | Unspecified | Inhibition | = | 4.7 | % | PMID[515146] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 40000.0 | nM | PMID[515147] |
NPT1531 | Organism | Enterococcus faecium | Enterococcus faecium | MIC | = | 40000.0 | nM | PMID[515147] |
NPT1531 | Organism | Enterococcus faecium | Enterococcus faecium | MIC | = | 75000.0 | nM | PMID[515147] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | Membrane integrity | = | 0.0 | % | PMID[515147] |
NPT27 | Others | Unspecified | Hemolysis | = | 100.0 | % | PMID[515147] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 2.2 | ug.mL-1 | PMID[515148] |
NPT1822 | Organism | Geobacillus stearothermophilus | Geobacillus stearothermophilus | MIC | = | 2.0 | ug.mL-1 | PMID[515149] |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 2.0 | ug.mL-1 | PMID[515149] |
NPT1823 | Organism | Bacillus coagulans | Bacillus coagulans | MIC | = | 2.0 | ug.mL-1 | PMID[515149] |
NPT1824 | Organism | Clostridium sporogenes | Clostridium sporogenes | MIC | = | 8.0 | ug.mL-1 | PMID[515149] |
NPT314 | Organism | Bacillus cereus | Bacillus cereus | MIC | = | 3.0 | ug.mL-1 | PMID[515149] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 3.0 | ug.mL-1 | PMID[515149] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 5.0 | ug.mL-1 | PMID[515149] |
NPT1825 | Organism | Lactobacillus plantarum | Lactobacillus plantarum | MIC | = | 5.0 | ug.mL-1 | PMID[515149] |
NPT175 | Organism | Enterococcus faecalis | Enterococcus faecalis | MIC | = | 6.0 | ug.mL-1 | PMID[515149] |
NPT1531 | Organism | Enterococcus faecium | Enterococcus faecium | MIC | = | 6.0 | ug.mL-1 | PMID[515149] |
NPT1826 | Organism | Lactococcus lactis | Lactococcus lactis | MIC | = | 8.0 | ug.mL-1 | PMID[515149] |
NPT878 | Organism | Streptococcus mutans | Streptococcus mutans | MIC | = | 5.0 | ug.mL-1 | PMID[515149] |
NPT451 | Organism | Helicobacter pylori | Helicobacter pylori | MIC | = | 25.0 | ug.mL-1 | PMID[515149] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 16.0 | ug.mL-1 | PMID[515149] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 6.25 | ug.mL-1 | PMID[515149] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 3.13 | ug.mL-1 | PMID[515149] |
NPT1827 | Organism | Mycobacterium bovis | Mycobacterium bovis | MIC | <= | 20.0 | ug.mL-1 | PMID[515149] |
NPT1828 | Organism | Mycobacterium kansasii | Mycobacterium kansasii | MIC | <= | 20.0 | ug.mL-1 | PMID[515149] |
NPT1829 | Organism | Mycobacterium xenopi | Mycobacterium xenopi | MIC | <= | 20.0 | ug.mL-1 | PMID[515149] |
NPT1830 | Organism | Mycobacterium marinum | Mycobacterium marinum | MIC | <= | 20.0 | ug.mL-1 | PMID[515149] |
NPT2 | Others | Unspecified | IC50 | = | 593000.0 | nM | PMID[515149] | |
NPT2 | Others | Unspecified | IC50 | = | 460000.0 | nM | PMID[515149] | |
NPT2 | Others | Unspecified | IC50 | = | 1519000.0 | nM | PMID[515149] | |
NPT2 | Others | Unspecified | IC50 | = | 1985000.0 | nM | PMID[515149] | |
NPT2 | Others | Unspecified | IC50 | = | 14000.0 | nM | PMID[515149] | |
NPT2 | Others | Unspecified | IC50 | = | 1400000.0 | nM | PMID[515149] | |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 4000.0 | nM | PMID[515149] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 650.0 | nM | PMID[515149] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 10300.0 | nM | PMID[515150] |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | <= | 20.0 | ug.mL-1 | PMID[515149] |
NPT2 | Others | Unspecified | IC50 | = | 1200.0 | nM | PMID[515151] | |
NPT2 | Others | Unspecified | IC50 | = | 1400.0 | nM | PMID[515151] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 6300.0 | nM | PMID[515152] |
NPT27 | Others | Unspecified | Activity | = | 19.9 | % | PMID[515152] | |
NPT27 | Others | Unspecified | Activity | = | 11.6 | % | PMID[515152] | |
NPT27 | Others | Unspecified | Activity | = | 47.9 | % | PMID[515152] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 18400.0 | nM | PMID[515152] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 100000.0 | nM | PMID[515152] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 4.2 | nM | PMID[515153] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 14000.0 | nM | PMID[515155] |
NPT2 | Others | Unspecified | Selectivity Index | = | 68300.0 | n.a. | PMID[515156] | |
NPT1188 | Organism | Plasmodium yoelii yoelii | Plasmodium yoelii yoelii | IC50 | = | 0.927 | nM | PMID[515156] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 4100.0 | nM | PMID[515157] |
NPT1188 | Organism | Plasmodium yoelii yoelii | Plasmodium yoelii yoelii | IC50 | = | 0.927 | nM | PMID[515160] |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | = | 7.1 | ug.mL-1 | PMID[515161] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 17000.0 | nM | PMID[515162] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1.43 | ug.mL-1 | PMID[515163] |
NPT2 | Others | Unspecified | IC50 | >= | 100000.0 | nM | PMID[515164] | |
NPT2 | Others | Unspecified | IC50 | = | 10800.0 | nM | PMID[515164] | |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | > | 65.0 | % | PMID[515164] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | > | 96.0 | % | PMID[515164] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 2700.0 | nM | PMID[515165] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 2.5 | ug.mL-1 | PMID[515165] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1.4 | ug.mL-1 | PMID[515166] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 7200.0 | nM | PMID[515166] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 900.0 | nM | PMID[515166] |
NPT35 | Others | n.a. | LogP | = | 4.74 | n.a. | PMID[515167] | |
NPT21742 | CELL-LINE | L02 | Homo sapiens | GI | = | 16.0 | % | PMID[515168] |
NPT2 | Others | Unspecified | Inhibition | = | 56.0 | % | PMID[515168] | |
NPT2 | Others | Unspecified | IC50 | = | 13900.0 | nM | PMID[515168] | |
NPT2 | Others | Unspecified | Inhibition | = | 1.0 | % | PMID[515168] | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 70.0 | U/L | PMID[515169] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 150.0 | U/L | PMID[515169] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 800.0 | U/L | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Cmax | = | 0.09678 | ug.mL-1 | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Tmax | = | 2.5 | hr | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | T1/2 | = | 10.33 | hr | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AUC | = | 836.7 | ng.hr.mL-1 | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AUC | = | 993.88 | ng.hr.mL-1 | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MRT(t) | = | 8.48 | hr | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MRT | = | 14.54 | hr | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CLz/F | = | 23.39 | L/hr/kg | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Vd/F | = | 369.65 | L.kg-1 | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | VRT(t) | = | 40.43 | hr2 | PMID[515169] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | VRT | = | 256.28 | hr2 | PMID[515169] |
NPT741 | Individual Protein | Tyrosinase | Homo sapiens | Inhibition | = | 10.6 | % | PMID[515170] |
NPT2 | Others | Unspecified | Inhibition | = | 57.2 | % | PMID[515170] | |
NPT2 | Others | Unspecified | IC50 | = | 13900.0 | nM | PMID[515170] | |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 0.5 | ug.mL-1 | PMID[515173] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 900.0 | nM | PMID[515173] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Activity | > | 90.0 | % | PMID[515174] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 7.2 | ug.mL-1 | PMID[515174] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 0.9 | ug.mL-1 | PMID[515174] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 62400.0 | nM | PMID[515175] |
NPT20 | Organism | Candida albicans | Candida albicans | MFC | = | 150.0 | uM | PMID[515175] |
NPT329 | Organism | Trichophyton rubrum | Trichophyton rubrum | MIC | = | 11520.0 | nM | PMID[515175] |
NPT23852 | CELL-LINE | HK-2 | Homo sapiens | IC50 | = | 88700.0 | nM | PMID[515176] |
NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | IC50 | = | 0.848 | ug.mL-1 | PMID[515177] |
NPT2 | Others | Unspecified | Ratio | = | 3.0 | n.a. | PMID[515179] | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Kd | > | 50000.0 | nM | PMID[515179] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Kd | = | 2810.0 | nM | PMID[515179] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Kd | = | 12810.0 | nM | PMID[515179] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[515179] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | IC50 | = | 5176.0 | nM | PMID[515179] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | IC50 | = | 76870.0 | nM | PMID[515179] |
NPT2 | Others | Unspecified | IC50 | > | 50000.0 | nM | PMID[515179] | |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | IC50 | = | 970.0 | nM | PMID[515180] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 94920.0 | nM | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 114810.0 | nM | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 121200.0 | nM | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 105410.0 | nM | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | FC | = | 1.0 | n.a. | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | FC | = | 0.8 | n.a. | PMID[515182] |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | FC | = | 0.9 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 4.44 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 4.53 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 4.55 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 4.73 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | FC | = | 1.1 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | FC | = | 1.0 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 9.73 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 11.01 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 10.7 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 11.74 | nM | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | FC | = | 0.9 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | FC | = | 0.8 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | IC50 | = | 10000.0 | nM | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | IC50 | = | 10000.0 | nM | PMID[515182] |
NPT2 | Others | Unspecified | IC50 | = | 10000.0 | nM | PMID[515182] | |
NPT21769 | CELL-LINE | GES1 | Homo sapiens | IC50 | > | 180000.0 | nM | PMID[515182] |
NPT23297 | CELL-LINE | LS180 | Homo sapiens | FC | = | 2.0 | n.a. | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 95.4 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 1.7 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 2.7 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 0.2 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 44.1 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 30.3 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 22.5 | % | PMID[515182] |
NPT26840 | CELL-LINE | S1 | Homo sapiens | Activity | = | 3.0 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 94.4 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 2.5 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 2.9 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 0.2 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 67.8 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 9.0 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 22.5 | % | PMID[515182] |
NPT26841 | CELL-LINE | S1-M1-80 | Homo sapiens | Activity | = | 0.8 | % | PMID[515182] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[515183] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[515183] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC23870 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9776 | High Similarity | NPC11056 |
0.9773 | High Similarity | NPC24394 |
0.9695 | High Similarity | NPC27643 |
0.9542 | High Similarity | NPC164236 |
0.9542 | High Similarity | NPC309717 |
0.9542 | High Similarity | NPC128348 |
0.9542 | High Similarity | NPC66384 |
0.9542 | High Similarity | NPC112192 |
0.9542 | High Similarity | NPC189106 |
0.9493 | High Similarity | NPC476055 |
0.9481 | High Similarity | NPC21350 |
0.9478 | High Similarity | NPC477243 |
0.9478 | High Similarity | NPC477242 |
0.9478 | High Similarity | NPC186838 |
0.9478 | High Similarity | NPC12165 |
0.9478 | High Similarity | NPC1486 |
0.9478 | High Similarity | NPC66349 |
0.9478 | High Similarity | NPC98115 |
0.9478 | High Similarity | NPC477244 |
0.9478 | High Similarity | NPC274109 |
0.9478 | High Similarity | NPC41461 |
0.9478 | High Similarity | NPC25287 |
0.9478 | High Similarity | NPC168105 |
0.9478 | High Similarity | NPC249606 |
0.9478 | High Similarity | NPC150399 |
0.9412 | High Similarity | NPC477956 |
0.9412 | High Similarity | NPC472366 |
0.9407 | High Similarity | NPC153979 |
0.9407 | High Similarity | NPC472419 |
0.9407 | High Similarity | NPC317119 |
0.9403 | High Similarity | NPC13575 |
0.9403 | High Similarity | NPC131039 |
0.9403 | High Similarity | NPC156092 |
0.9389 | High Similarity | NPC247779 |
0.9343 | High Similarity | NPC48624 |
0.9343 | High Similarity | NPC219917 |
0.9343 | High Similarity | NPC204985 |
0.9343 | High Similarity | NPC215311 |
0.9343 | High Similarity | NPC172250 |
0.9343 | High Similarity | NPC144118 |
0.9343 | High Similarity | NPC80962 |
0.9343 | High Similarity | NPC326109 |
0.9343 | High Similarity | NPC213659 |
0.9343 | High Similarity | NPC259166 |
0.9333 | High Similarity | NPC213603 |
0.9328 | High Similarity | NPC286336 |
0.9328 | High Similarity | NPC103842 |
0.9281 | High Similarity | NPC11700 |
0.9275 | High Similarity | NPC268204 |
0.9275 | High Similarity | NPC55832 |
0.9275 | High Similarity | NPC469404 |
0.9275 | High Similarity | NPC26051 |
0.9275 | High Similarity | NPC470089 |
0.9275 | High Similarity | NPC470087 |
0.9275 | High Similarity | NPC321980 |
0.9275 | High Similarity | NPC52789 |
0.927 | High Similarity | NPC470211 |
0.927 | High Similarity | NPC295384 |
0.927 | High Similarity | NPC283429 |
0.9254 | High Similarity | NPC242294 |
0.9254 | High Similarity | NPC82225 |
0.9254 | High Similarity | NPC175098 |
0.9254 | High Similarity | NPC337373 |
0.9254 | High Similarity | NPC56031 |
0.9254 | High Similarity | NPC144051 |
0.9254 | High Similarity | NPC28753 |
0.9254 | High Similarity | NPC18877 |
0.9254 | High Similarity | NPC263670 |
0.9254 | High Similarity | NPC192304 |
0.9254 | High Similarity | NPC188646 |
0.9254 | High Similarity | NPC139813 |
0.9254 | High Similarity | NPC159623 |
0.9254 | High Similarity | NPC294593 |
0.9254 | High Similarity | NPC312318 |
0.9254 | High Similarity | NPC204960 |
0.9254 | High Similarity | NPC20560 |
0.9254 | High Similarity | NPC472365 |
0.922 | High Similarity | NPC10990 |
0.922 | High Similarity | NPC300988 |
0.9214 | High Similarity | NPC471473 |
0.9214 | High Similarity | NPC471524 |
0.9214 | High Similarity | NPC471523 |
0.9209 | High Similarity | NPC297600 |
0.9203 | High Similarity | NPC265178 |
0.9203 | High Similarity | NPC253822 |
0.9203 | High Similarity | NPC101366 |
0.9197 | High Similarity | NPC243528 |
0.9197 | High Similarity | NPC472368 |
0.9197 | High Similarity | NPC251681 |
0.9197 | High Similarity | NPC471620 |
0.9191 | High Similarity | NPC473391 |
0.9191 | High Similarity | NPC472364 |
0.9191 | High Similarity | NPC472367 |
0.9191 | High Similarity | NPC476333 |
0.9179 | High Similarity | NPC205468 |
0.9179 | High Similarity | NPC87231 |
0.9179 | High Similarity | NPC129132 |
0.9179 | High Similarity | NPC212631 |
0.9179 | High Similarity | NPC257756 |
0.9149 | High Similarity | NPC25844 |
0.9149 | High Similarity | NPC477955 |
0.9143 | High Similarity | NPC18585 |
0.9143 | High Similarity | NPC166138 |
0.9143 | High Similarity | NPC117836 |
0.9143 | High Similarity | NPC301751 |
0.9143 | High Similarity | NPC106985 |
0.9143 | High Similarity | NPC105213 |
0.9143 | High Similarity | NPC245482 |
0.9143 | High Similarity | NPC51887 |
0.9143 | High Similarity | NPC476178 |
0.9143 | High Similarity | NPC475705 |
0.9137 | High Similarity | NPC40118 |
0.9137 | High Similarity | NPC49108 |
0.9137 | High Similarity | NPC232021 |
0.9137 | High Similarity | NPC126534 |
0.9137 | High Similarity | NPC110969 |
0.9124 | High Similarity | NPC162680 |
0.9124 | High Similarity | NPC181124 |
0.9124 | High Similarity | NPC303644 |
0.9124 | High Similarity | NPC7013 |
0.9124 | High Similarity | NPC116632 |
0.9124 | High Similarity | NPC209560 |
0.9124 | High Similarity | NPC294409 |
0.9104 | High Similarity | NPC308037 |
0.9104 | High Similarity | NPC475008 |
0.9104 | High Similarity | NPC64359 |
0.9104 | High Similarity | NPC186097 |
0.9104 | High Similarity | NPC475009 |
0.9104 | High Similarity | NPC262359 |
0.9104 | High Similarity | NPC313618 |
0.9091 | High Similarity | NPC471114 |
0.9078 | High Similarity | NPC234629 |
0.9078 | High Similarity | NPC311741 |
0.9078 | High Similarity | NPC157133 |
0.9078 | High Similarity | NPC328623 |
0.9078 | High Similarity | NPC271288 |
0.9071 | High Similarity | NPC148545 |
0.9071 | High Similarity | NPC11561 |
0.9071 | High Similarity | NPC226636 |
0.9071 | High Similarity | NPC144499 |
0.9065 | High Similarity | NPC159275 |
0.9065 | High Similarity | NPC172986 |
0.9065 | High Similarity | NPC241100 |
0.9065 | High Similarity | NPC270883 |
0.9065 | High Similarity | NPC261227 |
0.9065 | High Similarity | NPC69769 |
0.9058 | High Similarity | NPC477056 |
0.9058 | High Similarity | NPC124269 |
0.9058 | High Similarity | NPC12175 |
0.9058 | High Similarity | NPC477055 |
0.9058 | High Similarity | NPC55162 |
0.9058 | High Similarity | NPC279668 |
0.9058 | High Similarity | NPC278323 |
0.9058 | High Similarity | NPC90665 |
0.9058 | High Similarity | NPC309154 |
0.9044 | High Similarity | NPC164136 |
0.9037 | High Similarity | NPC215875 |
0.9037 | High Similarity | NPC15834 |
0.9028 | High Similarity | NPC188403 |
0.9028 | High Similarity | NPC321896 |
0.9028 | High Similarity | NPC476185 |
0.9021 | High Similarity | NPC152233 |
0.9021 | High Similarity | NPC135325 |
0.9021 | High Similarity | NPC39195 |
0.9014 | High Similarity | NPC316769 |
0.9007 | High Similarity | NPC75049 |
0.9007 | High Similarity | NPC164980 |
0.9007 | High Similarity | NPC169591 |
0.9007 | High Similarity | NPC175504 |
0.9007 | High Similarity | NPC150408 |
0.9007 | High Similarity | NPC149026 |
0.9007 | High Similarity | NPC39329 |
0.9007 | High Similarity | NPC143896 |
0.9007 | High Similarity | NPC257097 |
0.9007 | High Similarity | NPC221432 |
0.9007 | High Similarity | NPC68104 |
0.9007 | High Similarity | NPC310130 |
0.9007 | High Similarity | NPC91560 |
0.9 | High Similarity | NPC147688 |
0.9 | High Similarity | NPC156590 |
0.9 | High Similarity | NPC282300 |
0.9 | High Similarity | NPC3188 |
0.9 | High Similarity | NPC26238 |
0.9 | High Similarity | NPC103362 |
0.9 | High Similarity | NPC205006 |
0.9 | High Similarity | NPC118840 |
0.9 | High Similarity | NPC64908 |
0.8993 | High Similarity | NPC18260 |
0.8993 | High Similarity | NPC303633 |
0.8993 | High Similarity | NPC55018 |
0.8993 | High Similarity | NPC53181 |
0.8993 | High Similarity | NPC109232 |
0.8993 | High Similarity | NPC96565 |
0.8993 | High Similarity | NPC220062 |
0.8993 | High Similarity | NPC301217 |
0.8993 | High Similarity | NPC216978 |
0.8993 | High Similarity | NPC78913 |
0.8993 | High Similarity | NPC217186 |
0.8986 | High Similarity | NPC255801 |
0.8986 | High Similarity | NPC188879 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC23870 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9104 | High Similarity | NPD1240 | Approved |
0.8978 | High Similarity | NPD1510 | Phase 2 |
0.8971 | High Similarity | NPD1607 | Approved |
0.8944 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8681 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8652 | High Similarity | NPD1549 | Phase 2 |
0.8639 | High Similarity | NPD4380 | Phase 2 |
0.8582 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8582 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8561 | High Similarity | NPD6651 | Approved |
0.8533 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8531 | High Similarity | NPD3750 | Approved |
0.8511 | High Similarity | NPD2796 | Approved |
0.8467 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8467 | Intermediate Similarity | NPD7819 | Suspended |
0.8462 | Intermediate Similarity | NPD2800 | Approved |
0.8462 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8456 | Intermediate Similarity | NPD7411 | Suspended |
0.8421 | Intermediate Similarity | NPD7075 | Discontinued |
0.8389 | Intermediate Similarity | NPD6599 | Discontinued |
0.838 | Intermediate Similarity | NPD2935 | Discontinued |
0.8358 | Intermediate Similarity | NPD3972 | Approved |
0.8344 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8276 | Intermediate Similarity | NPD4628 | Phase 3 |
0.8273 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8264 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8231 | Intermediate Similarity | NPD6799 | Approved |
0.8217 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD3748 | Approved |
0.8158 | Intermediate Similarity | NPD6801 | Discontinued |
0.8158 | Intermediate Similarity | NPD1934 | Approved |
0.8125 | Intermediate Similarity | NPD6099 | Approved |
0.8125 | Intermediate Similarity | NPD6100 | Approved |
0.8117 | Intermediate Similarity | NPD3882 | Suspended |
0.8108 | Intermediate Similarity | NPD1511 | Approved |
0.8105 | Intermediate Similarity | NPD2801 | Approved |
0.8089 | Intermediate Similarity | NPD6232 | Discontinued |
0.8079 | Intermediate Similarity | NPD7458 | Discontinued |
0.8065 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8056 | Intermediate Similarity | NPD2799 | Discontinued |
0.8056 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8054 | Intermediate Similarity | NPD2532 | Approved |
0.8054 | Intermediate Similarity | NPD2534 | Approved |
0.8054 | Intermediate Similarity | NPD2533 | Approved |
0.805 | Intermediate Similarity | NPD7473 | Discontinued |
0.8027 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8027 | Intermediate Similarity | NPD7003 | Approved |
0.8027 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.8025 | Intermediate Similarity | NPD6959 | Discontinued |
0.8014 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8 | Intermediate Similarity | NPD1512 | Approved |
0.7959 | Intermediate Similarity | NPD1243 | Approved |
0.7949 | Intermediate Similarity | NPD3749 | Approved |
0.7945 | Intermediate Similarity | NPD2344 | Approved |
0.7926 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7902 | Intermediate Similarity | NPD943 | Approved |
0.7885 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7872 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7857 | Intermediate Similarity | NPD2798 | Approved |
0.7853 | Intermediate Similarity | NPD5953 | Discontinued |
0.7848 | Intermediate Similarity | NPD5494 | Approved |
0.784 | Intermediate Similarity | NPD5844 | Phase 1 |
0.784 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD920 | Approved |
0.7829 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7764 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7764 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7764 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7762 | Intermediate Similarity | NPD3268 | Approved |
0.7758 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7754 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7748 | Intermediate Similarity | NPD7390 | Discontinued |
0.7733 | Intermediate Similarity | NPD2309 | Approved |
0.773 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7721 | Intermediate Similarity | NPD9545 | Approved |
0.7714 | Intermediate Similarity | NPD1876 | Approved |
0.7707 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7697 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7669 | Intermediate Similarity | NPD3818 | Discontinued |
0.766 | Intermediate Similarity | NPD1203 | Approved |
0.766 | Intermediate Similarity | NPD2797 | Approved |
0.7639 | Intermediate Similarity | NPD3764 | Approved |
0.7639 | Intermediate Similarity | NPD2313 | Discontinued |
0.7626 | Intermediate Similarity | NPD422 | Phase 1 |
0.7613 | Intermediate Similarity | NPD3226 | Approved |
0.7603 | Intermediate Similarity | NPD230 | Phase 1 |
0.76 | Intermediate Similarity | NPD2654 | Approved |
0.7597 | Intermediate Similarity | NPD5403 | Approved |
0.7591 | Intermediate Similarity | NPD1548 | Phase 1 |
0.759 | Intermediate Similarity | NPD6559 | Discontinued |
0.7582 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7571 | Intermediate Similarity | NPD1608 | Approved |
0.7569 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7568 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7536 | Intermediate Similarity | NPD1651 | Approved |
0.7535 | Intermediate Similarity | NPD1164 | Approved |
0.7532 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7515 | Intermediate Similarity | NPD7054 | Approved |
0.75 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7485 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7484 | Intermediate Similarity | NPD4288 | Approved |
0.7483 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.747 | Intermediate Similarity | NPD7472 | Approved |
0.7468 | Intermediate Similarity | NPD5401 | Approved |
0.7467 | Intermediate Similarity | NPD2346 | Discontinued |
0.7467 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7465 | Intermediate Similarity | NPD1283 | Approved |
0.7453 | Intermediate Similarity | NPD919 | Approved |
0.7448 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7447 | Intermediate Similarity | NPD9717 | Approved |
0.7445 | Intermediate Similarity | NPD9493 | Approved |
0.7425 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7425 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7423 | Intermediate Similarity | NPD5711 | Approved |
0.7423 | Intermediate Similarity | NPD5710 | Approved |
0.7413 | Intermediate Similarity | NPD1470 | Approved |
0.7413 | Intermediate Similarity | NPD3266 | Approved |
0.7413 | Intermediate Similarity | NPD3267 | Approved |
0.7405 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7403 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.74 | Intermediate Similarity | NPD5408 | Approved |
0.74 | Intermediate Similarity | NPD5404 | Approved |
0.74 | Intermediate Similarity | NPD5406 | Approved |
0.74 | Intermediate Similarity | NPD5405 | Approved |
0.7397 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD7251 | Discontinued |
0.7376 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7376 | Intermediate Similarity | NPD1201 | Approved |
0.7375 | Intermediate Similarity | NPD5402 | Approved |
0.7365 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7365 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7362 | Intermediate Similarity | NPD1247 | Approved |
0.7357 | Intermediate Similarity | NPD4626 | Approved |
0.7357 | Intermediate Similarity | NPD17 | Approved |
0.7353 | Intermediate Similarity | NPD1241 | Discontinued |
0.7343 | Intermediate Similarity | NPD3225 | Approved |
0.7337 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7333 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD7033 | Discontinued |
0.7317 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7314 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7314 | Intermediate Similarity | NPD4363 | Phase 3 |
0.731 | Intermediate Similarity | NPD9494 | Approved |
0.7308 | Intermediate Similarity | NPD6273 | Approved |
0.7297 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7285 | Intermediate Similarity | NPD4476 | Approved |
0.7285 | Intermediate Similarity | NPD4477 | Approved |
0.7279 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7278 | Intermediate Similarity | NPD3658 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7273 | Intermediate Similarity | NPD4749 | Approved |
0.7273 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7262 | Intermediate Similarity | NPD1729 | Discontinued |
0.726 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7254 | Intermediate Similarity | NPD1281 | Approved |
0.725 | Intermediate Similarity | NPD37 | Approved |
0.7248 | Intermediate Similarity | NPD6355 | Discontinued |
0.7235 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7197 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7192 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7183 | Intermediate Similarity | NPD3847 | Discontinued |
0.7181 | Intermediate Similarity | NPD1613 | Approved |
0.7181 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7181 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD940 | Approved |
0.7176 | Intermediate Similarity | NPD6104 | Discontinued |
0.7176 | Intermediate Similarity | NPD846 | Approved |
0.7169 | Intermediate Similarity | NPD5242 | Approved |
0.7164 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7162 | Intermediate Similarity | NPD6798 | Discontinued |
0.7161 | Intermediate Similarity | NPD2354 | Approved |
0.716 | Intermediate Similarity | NPD2296 | Approved |
0.7152 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7143 | Intermediate Similarity | NPD7177 | Discontinued |
0.7143 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7135 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD6234 | Discontinued |
0.7133 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7124 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7124 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7124 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7117 | Intermediate Similarity | NPD4965 | Approved |
0.7117 | Intermediate Similarity | NPD4966 | Approved |
0.7117 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7113 | Intermediate Similarity | NPD2932 | Approved |
0.7113 | Intermediate Similarity | NPD3019 | Approved |
0.7113 | Intermediate Similarity | NPD1778 | Approved |
0.7111 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD8651 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.